As part of the agreement, technology veterans John G. Freeland and Stephen F. Schuckenbrock will be added to the company's slate of nominees for election to the Compuware Board of Directors at its 2013 annual meeting of shareholders, which is scheduled to occur in March of 2014.
John G. Freeland has more than thirty years of executive management and operational experience within the technology sector, including significant expertise in enterprise information solutions and services. From 2007 to 2012, he was President and CEO of SymphonyIRI Group, a marketing services provider to the CPG and over-the-counter healthcare industries, where he changed the mix of business from lower margin market measurement services to higher margin analytics and shopper marketing services. From 2005 to 2007, Mr. Freeland was President of Worldwide Operations at salesforce.com, a leader in the software as a service (SaaS) arena. Prior to this, Mr. Freeland served in various leadership roles, including Global Managing Partner, and as a member of the Executive Committee during his 26-year career at Accenture.
Stephen Schuckenbrock has nearly thirty years of experience leading IT organizations, consulting businesses, and hardware companies. He has served as President and CEO of Accretive Health, Inc. since April 2013, leading the company through a significant restructuring. From 2007 to 2013, Mr. Schuckenbrock served in multiple roles at Dell, Inc., most recently as the President of Dell Services and a member of the Executive Leadership Team. Prior to working at Dell, he served as Co-Chief Operating Officer and Executive Vice President of Global Sales and Services at Electronic Data Systems. Before joining EDS in 2003, Mr. Schuckenbrock served as Chief Operating Officer of The Feld Group, Global Chief Information Officer of PepsiCo, and spent almost a decade at IBM in a variety of Sales and Executive Staff positions. He currently serves on the Board of Accretive Health and has held previous directorship positions at Staples, Inc. and AT Kearney.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts